Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11964989 KRas G12D inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 24 Apr, 2024
"Created via: Patent importer"
Golden AI
created this topic on 24 Apr, 2024
Edits made to:
Infobox
(
+40
properties)
US Patent 11964989 KRas G12D inhibitors
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11964989
0
Patent Inventor Names
Aaron Craig Burns
0
Brad Newhouse
0
Christopher Ronald Smith
0
Dean Russell Kahn
0
Donghua Dai
0
Guy P.A. Vigers
0
Jacob Matthew O'Leary
0
James F. Blake
0
James Gail Christensen
0
Jay Bradford Fell
0
John David Lawson
0
John Gaudino
0
John Michael Ketcham
0
John Peter Fischer
0
Joshua Ryan Dahlke
0
Macedonio J. Mejia
0
Mark Joseph Chicarelli
0
Martha E. Rodriguez
0
Matthew Arnold Marx
0
Michael Christopher Hilton
0
Pavel Savechenkov
0
Phong Nguyen
0
Qian Zhao
0
Shelley Allen
0
Spencer Pajk
0
Tony P. Tang
0
Xiaolun Wang
0
Date of Patent
April 23, 2024
0
Patent Application Number
17869575
0
Date Filed
July 20, 2022
0
Patent Citations
US Patent 8163763 Pyrimidine compounds, compositions and methods of use
0
US Patent 8426401 Azetidinyl diamides as monoacylglycerol lipase inhibitors
0
US Patent 9562019 Substituted pyridazines as EGFR and/or KRAS inhibitors
0
US Patent 9840516 Substituted quinazolines as inhibitors of KRAS G12C
0
US Patent 10125134 KRas G12C inhibitors
0
Patent Primary Examiner
Kahsay Habte
0
CPC Code
C07D 519/00
0
Find more entities like US Patent 11964989 KRas G12D inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE